Estrogenic activity of bisphenol A and 2,2-bis(p-Hydroxyphenyl)-1,1,1-trichloroethane (HPTE) demonstrated in mouse uterine gene profiles

Environmental Health Perspectives

Volumn 119, Issue 1, 2011, Pages 63-70

  Hewitt, Sylvia C ^a   Korach, Kenneth S ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

BPA; ER ; Estrogen; HPTE; Microarray; Uterus

Indexed keywords

1,1,1 TRICHLORO 2,2 BIS(4 HYDROXYPHENYL)ETHANE; 4,4' ISOPROPYLIDENEDIPHENOL; ALKANE DERIVATIVE; ESTRADIOL; ESTRIOL; ESTROGEN RECEPTOR ALPHA; RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE SILENCING; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCTIVE TOXICITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UTERUS; WILD TYPE;

ANIMALS; ESTRIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; KI-67 ANTIGEN; MALE; MICE; MICE, KNOCKOUT; PHENOLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTERUS;

MUS;

EID: 78751492254     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1002347     Document Type: Article

References (47)

1. Ashby J, Odum J. 2004. Gene expression changes in the immature rat uterus: effects of uterotrophic and sub-uterotrophic doses of bisphenol A. Toxicol Sci 82(2):458-467.
2. Björnström L, Sjöberg M. 2005. Mechanisms of estrogen receptor signaling: convergence of genomic and non genomic actions on target genes. Mol Endocrinol 19(4):833-842.
3. Boehme K, Simon S, Mueller SO. 2009. Gene expression profl-ing in Ishikawa cells: a fingerprint for estrogen active compounds. Toxicol Appl Pharmacol 236(1):85-96.
4. Borgeest C, Symonds D, Mayer LP, Hoyer PB, Flaws JA. 2002. Methoxychlor may cause ovarian follicular atresia and proliferation of the ovarian epithelium in the mouse. Toxicol Sci 68(2):473-478.
5. Celik L, Lund JDD, Schiøtt B. 2008. Exploring interactions of endocrine-disrupting compounds with different conformations of the human estrogen receptor α ligand binding domain: a molecular docking study. Chem Res Toxicol 21(11):2195-2206.
6. Clark JH, Markaverich BM. 1984. The agonistic and antagonistic actions of estriol. J Steroid Biochem Mol Biol 20(4B):1005-1013.
7. Couse JF, Curtis SW, Washburn TF, Lindzey J, Golding TS, Lubahn DB, et al. 1995. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol Endocrinol 9:1441-1454.
8. Dey S, Soliman AS, Merajver SD. 2009. Xenoestrogens may be the cause of high and increasing rates of hormone receptor positive breast cancer in the world. Med Hypoth 72(6):652-656.
9. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, et al. 2009. Endocrine-disrupting chemicals: an endocrine society scientifc statement. Endocr Rev 30(4):293-342.
10. Dodds EC, Fitzgerald MEH, Lawson W. 1937. Oestrogenic activity of some hydrocarbon derivatives of ethylene. Nature 140:772-772.
11. Fujimoto N, Honda H, Kitamura S. 2004. Effects of environmental estrogenic chemicals on AP1 mediated transcription with estrogen receptors α and β. J Steroid Biochem Mol Biol 88(1):53-59.
12. Gaido KW, Leonard LS, Maness SC, Hall JM, McDonnell DP, Saville B, et al. 1999. Differential interaction of the methoxy chlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane with estrogen receptors α and β. Endocrinology 140(12):5746-5753.
13. Gaido KW, Maness SC, McDonnell DP, Dehal SS, Kupfer D, Safe S. 2000. Interaction of methoxychlor and related compounds with estrogen receptor α and β, and andro-gen receptor: structure-activity studies. Mol Pharmacol 58(4):852-858.
14. Gordon MD, Nusse R. 2006. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281(32):22429-22433.
15. Gray J, Evans N, Taylor B, Rizzo J, Walker M. 2009. State of the evidence: the connection between breast cancer and the environment. Int J Occup Environ Health 15(1):43-78.
16. Hewitt SC, Collins J, Grissom S, Deroo B, Korach KS. 2005. Global uterine genomics in vivo: microarray evaluation of the estrogen receptor α-growth factor cross-talk mechanism. Mol Endocrinol 19(3):657-668.
17. Hewitt SC, Collins J, Grissom S, Hamilton K, Korach KS. 2006. Estren behaves as a weak estrogen rather than a non genomic selective activator in the mouse uterus. Endocrinology 147(5):2203-2214.
18. Hewitt SC, Deroo BJ, Hansen K, Collins J, Grissom S, Afshari CA, et al. 2003. Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physio logical response to estrogen. Mol Endocrinol 17(10):2070-2083.
19. Hewitt, SC, Kissling GE, Fieselman KE, Jayes FL, Gerrish KE, Korach KS. 2010a. Biological and biochemical consequences of global deletion of exon 3 from the ERα gene. FASEB J 24(12):4660-4667; misctextdoi: 10.1096/fj.10-163428 Online 28 July 2010/misctext].
20. Hewitt SC, Li Y, Li L, Korach KS. 2010b. Estrogen-mediated regulation of Igf1 transcription and uterine growth involves direct binding of estrogen receptor α to estrogen-responsive elements. J Biol Chem 285(4):2676-2685.
21. Hewitt SC, O'Brien JE, Jameson JL, Kissling GE, Korach KS. 2009. Selective disruption of ER α DNA-binding activity alters uterine responsiveness to estradiol. Mol Endocrinol 23(12):2111-2116.
22. Institute of Laboratory Animal Resources. 1996. Guide for the Care and Use of Laboratory Animals. Washington, DC:National Academy Press. Available: http://oacu.od.nih. gov/regs/guide/guide.pdf [accessed 1 November 2010].
23. Jakacka M, Ito M, Weiss J, Chien PY, Gehm BD, Jameson JL. 2001. Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem 276(17):13615-13621.
24. Katzenellenbogen BS. 1984. Biology and receptor inter actions of estriol and estriol derivatives in vitro and in vivo. J Steroid Biochem 20(4b):1033-1037.
25. Klotz DM, Hewitt SC, Korach KS, Diaugustine RP. 2000. Activation of a uterine insulin-like growth factor I signaling pathway by clinical and environmental estrogens: requirement of estrogen receptor-α. Endocrinology 141(9):3430-3439.
26. Lan NC, Katzenellenbogen BS. 1976. Temporal relationships between hormone receptor binding and biological responses in the uterus: studies with short- and long-acting derivatives of estriol. Endocrinology 98(1):220-227.
27. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. 1993. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90(23):11162-11166.
28. Markey CM, Michaelson CL, Veson EC, Sonnenschein C, Soto AM. 2001. The mouse uterotrophic assay: a reevalua-tion of its validity in assessing the estrogenicity of bisphe-nol A. Environ Health Perspect 109:55-60.
29. Miller KR, Gupta RK, Flaws JA. 2006. Methoxychlor metabolites may cause ovarian toxicity through estrogen-regulated pathways. Toxicol Sci 93(1):180-188.
30. Moggs JG. 2005. Molecular responses to xenoestrogens: mechanistic insights from toxicogenomics. Toxicology 213(3):177-193.
31. Myers JP, vom Saal FS, Akingbemi BT, Arizono K, Belcher S, Colborn T, et al. 2009. Why public health agencies cannot depend on Good Laboratory Practices as a criterion for selecting data: the case of bisphenol A. Environ Health Perspect 117:309-315.
32. National Center for Biotechnology Information. 2010. Gene Expression Omnibus. Available: http://www.ncbi.nlm.nih. gov/geo/ [accessed 2 November 2010].
33. Newbold RR, Jefferson WN, Padilla-Banks E, Walker VR, Pena DS. 2001. Cell response endpoints enhance sensitivity of the immature mouse uterotropic assay. Reprod Toxicol 15(3):245-252.
34. O'Brien JE, Peterson TJ, Tong MH, Lee EJ, Pfaff LE, Hewitt SC, et al. 2006. Estrogen-induced proliferation of uterine epithelial cells is independent of estrogen receptor α binding to classical estrogen response elements. J Biol Chem 281(36):26683-26692.
35. O'Lone R, Frith MC, Karlsson EK, Hansen U. 2004. Genomic targets of nuclear estrogen receptors. Mol Endocrinol 18(8):1859-1875.
36. Ray S, Xu F, Wang H, Das SK. 2008. Cooperative control via lymphoid enhancer factor 1/t cell factor 3 and estrogen receptor-α for uterine gene regulation by estrogen. Mol Endocrinol 22(5):1125-1140.
37. Safe S, Kim K. 2008. Non-classical genomic estrogen receptor (ER)/specifcity protein and ER/activating protein-1 signaling pathways. J Mol Endocrinol 41(5-6):263-275.
38. Safe SH, Pallaroni L, Yoon K, Gaido K, Ross S, Saville B, et al. 2001. Toxicology of environmental estrogens. Reprod Fertil Dev 13(4):307-315.
39. Tiemann U. 2008. In vivo and in vitro effects of the organochlo-rine pesticides DDT, TCPM, methoxychlor, and lindane on the female reproductive tract of mammals: a review. Reprod Toxicol 25(3):316-326.
40. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. 2007. Human exposure to bisphenol A (BPA). Reprod Toxicol 24(2):139-177.
41. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM. 2009. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 30(1):75-95.
42. vom Saal FS, Akingbemi BT, Belcher SM, Birnbaum LS, Crain DA, Eriksen M, et al. 2007. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 24(2):131-138.
43. Waters KM, Safe S, Gaido KW. 2001. Differential gene expression in response to methoxychlor and estradiol through ER α, ER β, and AR in reproductive tissues of female mice. Toxicol Sci 63(1):47-56.
44. Weng L, Dai HY, Zhan YH, He YD, Stepaniants SB, Bassett DE. 2006. Rosetta error model for gene expression analysis. Bioinformatics 22(9):1111-1121.
45. Wu F, Khan S, Wu Q, Barhoumi R, Burghardt R, Safe S. 2008. Ligand structure-dependent activation of estrogen receptor α/Sp by estrogens and xeno estrogens. J Steroid Biochem Mol Biol 110(1-2):104-115.
46. Yoon K, Pellaroni L, Ramamoorthy K, Gaido K, Safe S. 2000. Ligand structure-dependent differences in activation of estrogen receptor α in human HepG2 liver and U2 osteogenic cancer cell lines. Mol Cell Endocrinol 162(1-2):211-220.
47. Yoshida T, Kitaura H, Hagio Y, Sato T, Iguchi-Ariga SMM, Ariga H. 2008. Negative regulation of the Wnt signal by MM-1 through inhibiting expression of the wnt4 gene. Exp Cell Res 314(6):1217-1228.